Skip to main content
Neural Regeneration Research logoLink to Neural Regeneration Research
. 2021 Sep 17;17(5):958. doi: 10.4103/1673-5374.295353

Retraction: Nafamostat mesylate attenuates the pathophysiologic sequelae of neurovascular ischemia

PMCID: PMC8552831  PMID: 34558547

This article has been retracted: please see Neural Regeneration Research (NRR) Policy on Article Retraction

(http://www.nrronline.org/contributors.asp).

The Editors of NRR have retracted the following article entitled “Nafamostat mesylate attenuates the pathophysiologic sequelae of neurovascular ischemia” (2020;15:2217-2234. doi: 10.4103/1673-5374.284981).

An investigation by Drexel University and University of California San Francisco has determined that the study was found using fraudulent affiliations. The author, Michael George Zaki Ghali, cannot provide valid evidence to prove the authenticity of his affiliation. As accurately stating the authorship, affiliated institution, ethics approval and the source of funding is core to the integrity of published work, we are therefore retracting the article. The corresponding author listed in this publication has been informed. The authors did not agree with the decision to retract the article.

Reference

  • 1.Ghali GZ, Ghali MG. Nafamostat mesylate attenuates the pathophysiologic sequelae of neurovascular ischemia. Neural Regen Res. 2020;15:2217–2234. doi: 10.4103/1673-5374.284981. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]

Articles from Neural Regeneration Research are provided here courtesy of Wolters Kluwer -- Medknow Publications

RESOURCES